David A. Siegel Biomea Fusion, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 117,600 shares of BMEA stock, worth $756,168. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117,600
Previous 110,700
6.23%
Holding current value
$756,168
Previous $498,000
138.35%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BMEA
# of Institutions
105Shares Held
17.9MCall Options Held
1.68MPut Options Held
410K-
Cormorant Asset Management, LP Boston, MA3.57MShares$23 Million2.53% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$15.1 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$13.6 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$8.99 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.38MShares$8.86 Million0.01% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $188M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...